Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12848 | 815 | 40.1 | 91% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VISFATIN | Author keyword | 383 | 68% | 41% | 336 |
2 | NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | Author keyword | 61 | 77% | 5% | 41 |
3 | NAMPT | Author keyword | 53 | 59% | 7% | 59 |
4 | FK866 | Author keyword | 51 | 91% | 3% | 21 |
5 | PRE B CELL COLONY ENHANCING FACTOR | Author keyword | 41 | 87% | 2% | 20 |
6 | PBEF | Author keyword | 40 | 79% | 3% | 26 |
7 | PRE B CELL COLONY ENHANCING FACTOR PBEF | Author keyword | 23 | 100% | 1% | 10 |
8 | CHS 828 | Author keyword | 17 | 68% | 2% | 15 |
9 | APO866 | Author keyword | 12 | 86% | 1% | 6 |
10 | NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT | Author keyword | 7 | 67% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VISFATIN | 383 | 68% | 41% | 336 | Search VISFATIN | Search VISFATIN |
2 | NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | 61 | 77% | 5% | 41 | Search NICOTINAMIDE+PHOSPHORIBOSYLTRANSFERASE | Search NICOTINAMIDE+PHOSPHORIBOSYLTRANSFERASE |
3 | NAMPT | 53 | 59% | 7% | 59 | Search NAMPT | Search NAMPT |
4 | FK866 | 51 | 91% | 3% | 21 | Search FK866 | Search FK866 |
5 | PRE B CELL COLONY ENHANCING FACTOR | 41 | 87% | 2% | 20 | Search PRE+B+CELL+COLONY+ENHANCING+FACTOR | Search PRE+B+CELL+COLONY+ENHANCING+FACTOR |
6 | PBEF | 40 | 79% | 3% | 26 | Search PBEF | Search PBEF |
7 | PRE B CELL COLONY ENHANCING FACTOR PBEF | 23 | 100% | 1% | 10 | Search PRE+B+CELL+COLONY+ENHANCING+FACTOR+PBEF | Search PRE+B+CELL+COLONY+ENHANCING+FACTOR+PBEF |
8 | CHS 828 | 17 | 68% | 2% | 15 | Search CHS+828 | Search CHS+828 |
9 | APO866 | 12 | 86% | 1% | 6 | Search APO866 | Search APO866 |
10 | NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT | 7 | 67% | 1% | 6 | Search NICOTINAMIDE+PHOSPHORIBOSYLTRANSFERASE+NAMPT | Search NICOTINAMIDE+PHOSPHORIBOSYLTRANSFERASE+NAMPT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COLONY ENHANCING FACTOR | 426 | 66% | 48% | 393 |
2 | PLASMA VISFATIN | 196 | 89% | 11% | 89 |
3 | SERUM VISFATIN | 185 | 91% | 9% | 75 |
4 | FK866 | 98 | 100% | 4% | 29 |
5 | NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE | 86 | 57% | 13% | 103 |
6 | ADIPOCYTOKINE VISFATIN | 81 | 96% | 3% | 25 |
7 | NAMPT PBEF VISFATIN | 65 | 95% | 3% | 21 |
8 | CHS 828 | 58 | 92% | 3% | 23 |
9 | NAD BIOSYNTHESIS | 40 | 46% | 8% | 66 |
10 | NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT | 33 | 100% | 2% | 13 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer | 2015 | 2 | 83 | 75% |
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review | 2011 | 62 | 60 | 80% |
Nampt: linking NAD biology, metabolism and cancer | 2009 | 137 | 84 | 64% |
Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and Pathophysiology | 2012 | 38 | 90 | 57% |
Visfatin, glucose metabolism and vascular disease: a review of evidence | 2010 | 37 | 36 | 94% |
Visfatin/Nampt: An Adipokine with Cardiovascular Impact | 2013 | 14 | 112 | 75% |
Nampt/PBEF/visfatin and cancer | 2010 | 51 | 69 | 72% |
The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer | 2010 | 56 | 24 | 63% |
Pre-B Cell Colony Enhancing Factor/NAMPT/Visfatin in Inflammation and Obesity-Related Disorders | 2010 | 50 | 84 | 63% |
Nicotinamide Phosphoribosyltransferase (Nampt): A Link Between NAD Biology, Metabolism, and Diseases | 2009 | 70 | 57 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GRP RECERCA MED LICADAIISPV | 2 | 67% | 0.2% | 2 |
2 | INTRAMURAL DHHS | 1 | 100% | 0.2% | 2 |
3 | ENDOCRINOL METAB GRP | 1 | 15% | 1.0% | 8 |
4 | PEDIAT LEIPZIG | 1 | 30% | 0.4% | 3 |
5 | NICHDNIH | 1 | 40% | 0.2% | 2 |
6 | ARTERIAL HYPERTENS DIABETOL | 1 | 27% | 0.4% | 3 |
7 | HLTH PROMOT OBES MANAGEMENT UNIT | 1 | 15% | 0.7% | 6 |
8 | PEDIAT LEIPZIG CPL | 1 | 33% | 0.2% | 2 |
9 | PHARM MED SOSNOWIEC | 1 | 33% | 0.2% | 2 |
10 | DENTOMAXILLO IAL MED | 1 | 18% | 0.5% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000173435 | CHEMERIN//VASPIN//OMENTIN |
2 | 0.0000106478 | WLDS//NMNAT//NAD BIOSYNTHESIS |
3 | 0.0000100519 | RESISTIN//RESISTIN LIKE MOLECULE BETA//RELM ALPHA |
4 | 0.0000099720 | APELIN//APJ//APELIN 13 |
5 | 0.0000088762 | NEIRID//MOL CELLULAR CARDIOL 7//NEIRID NEUROENDOCRINE INTERACT RHEUMATOL IN |
6 | 0.0000087394 | SIRT1//SIRTUIN//SIRT3 |
7 | 0.0000064515 | ADIPONECTIN//ADIPONECTIN RECEPTOR//ADIPONECTIN RECEPTORS |
8 | 0.0000060634 | RETINOL BINDING PROTEIN 4//RBP4//STRA6 |
9 | 0.0000048037 | SVFP//ECREIN//ADIPOR2 |
10 | 0.0000037819 | CTRP3//CTRP 3//CTRP5 |